The Energy and Commerce Committee is leading to increase patient access to care and support providers. In a Full Committee markup, E&C advanced solutions to lower the cost of drugs, encourage Medicare innovation, and help equip Americans with the tools they need to make the best health care decisions. 

Legislative vote summary:

• H.R. 5372, Expanding Seniors’ Access to Lower Cost Medicines Act of 2023, was reported, as amended, to the Full House by a roll call vote of 48 yeas to 0 nays.  
• H.R. 2880, Protecting Patients Against PBM Abuses Act, was reported to the Full House, as amended, by a roll call vote of 46 yeas to 0 nays. 
• H.R. 5393, To amend title XVIII of the Social Security Act to ensure fair assessment of pharmacy performance and quality under Medicare part D, and for other purposes, was reported to the Full House by a roll call vote of 44 yeas to 0 nays. 
• H.R. 5385, Medicare PBM Accountability Act, was reported to the Full House, as amended, by a roll call vote of 44 yeas to 0 nays. 
• H.R. 5386, Cutting Copays Act, was reported to the Full House, as amended, by a roll call vote of 41 yeas to 1 nay. 
• H.R. 4881, To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program, was reported to the Full House, as amended, by a roll call vote of 45 yeas to 0 nays. 
• H.R. 5389, National Coverage Determination Transparency Act, was reported to the Full House, as amended, by a roll call vote of 46 yeas to 0 nays. 
• H.R. 133, Mandating Exclusive Review of Individual Treatments (MERIT) Act, was reported to the Full House, as amended, by a roll call vote of 42 yeas to 0 nays. 
• H.R. 5396, Coverage Determination Clarity Act of 2023, was reported to the Full House, as amended, by a roll call vote of 44 yeas to 0 nays. 
• H.R. 5371, Choices for Increased Mobility Act of 2023, was reported to the Full House, as amended, by a roll call vote of 41 yeas to 0 nays. 
• H.R. 5388, Supporting Innovation for Seniors Act, was reported to the Full House, as amended, by a roll call vote of 43 yeas to 0 nays. 
• H.R. 5380, To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage, was reported to the Full House, as amended, by a roll call vote of 43 yeas to 0 nays. 
• H.R. 3842, Expanding Access to Diabetes Self-Management Training Act of 2023, was reported to the Full House, as amended, by a roll call vote of 44 yeas to 0 nays. 
• H.R. 5397, Joe Fiandra Access to Home Infusion Act of 2023, was reported to the Full House, as amended, by a roll call vote of 46 yeas to 0 nays. 
• H.R. 5555, DMEPOS Relief Act of 2023, was reported to the Full House, as amended, by a voice vote. 
• H.R. 2365, National Plan to End Parkinson’s Act, was reported to the Full House, as amended, by a roll call vote of 47 yeas to 0 nays. 
• H.R. 6545, Physician Fee Schedule Update and Improvements Act, was reported to the Full House, as amended, by a roll call vote of 46 yeas to 0 nays. 
• H.R. 6364, Medicare Telehealth Privacy Act of 2023, was reported to the Full House, as amended, by a roll call vote of 44 yeas to 0 nays. 
• H.R. 1352, Increasing Access to Biosimilars Act of 2023, was reported to the Full House, as amended, by a roll call vote of 44 yeas to 0 nays.